Section 1 Extending eligibility for certain payment increases for biosimilar biological products under the Medicare program
Section 1847A(b)(8)(B)(ii)(II) of the Social Security Act (42 U.S.C. 1395w–3a(b)(8)(B)(ii)(II)) is amended by striking “2027” and inserting “2032”.